Cargando…
Update on Dihydropteroate Synthase (DHPS) Mutations in Pneumocystis jirovecii
A Pneumocystis jirovecii is one of the most important microorganisms that cause pneumonia in immunosupressed individuals. The guideline for treatment and prophylaxis of Pneumocystis pneumonia (PcP) is the use of a combination of sulfa drug-containing trimethroprim and sulfamethoxazole. In the absenc...
Autores principales: | de la Horra, Carmen, Friaza, Vicente, Morilla, Rubén, Delgado, Juan, Medrano, Francisco J., Miller, Robert F., de Armas, Yaxsier, Calderón, Enrique J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540849/ https://www.ncbi.nlm.nih.gov/pubmed/34682277 http://dx.doi.org/10.3390/jof7100856 |
Ejemplares similares
-
Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population
por: Morilla, Rubén, et al.
Publicado: (2019) -
Pneumocystis jirovecii among patients with cystic fibrosis and their household members
por: Morilla, Ruben, et al.
Publicado: (2021) -
Multilocus Genotyping of Pneumocystis jirovecii from Deceased Cuban AIDS Patients Using Formalin-Fixed and Paraffin-Embedded Tissues
por: Friaza, Vicente, et al.
Publicado: (2021) -
Pneumocystis jirovecii Transmission from Immunocompetent Carriers to Infant
por: Rivero, Laura, et al.
Publicado: (2008) -
Sulfa Use, Dihydropteroate Synthase Mutations, and Pneumocystis jirovecii Pneumonia
por: Stein, Cheryl R., et al.
Publicado: (2004)